Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HMGN1 Protein | 1 | 2018 | 3 | 0.610 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 1762 | 0.600 |
Why?
|
| Trisomy | 1 | 2018 | 112 | 0.570 |
Why?
|
| Down Syndrome | 1 | 2018 | 232 | 0.480 |
Why?
|
| Re-Epithelialization | 1 | 2014 | 12 | 0.440 |
Why?
|
| Lipocalins | 1 | 2014 | 30 | 0.440 |
Why?
|
| Wilms Tumor | 1 | 2015 | 119 | 0.440 |
Why?
|
| Acute-Phase Proteins | 1 | 2014 | 50 | 0.440 |
Why?
|
| Keratinocytes | 1 | 2014 | 66 | 0.430 |
Why?
|
| Genetic Markers | 1 | 2015 | 635 | 0.420 |
Why?
|
| Repressor Proteins | 2 | 2015 | 874 | 0.420 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 157 | 0.420 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2025 | 277 | 0.410 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 231 | 0.380 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 405 | 0.370 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 721 | 0.360 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 462 | 0.350 |
Why?
|
| Skin | 1 | 2014 | 545 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2024 | 218 | 0.350 |
Why?
|
| Lentivirus | 1 | 2011 | 86 | 0.340 |
Why?
|
| Genetic Techniques | 1 | 2011 | 109 | 0.340 |
Why?
|
| Cell Movement | 1 | 2014 | 920 | 0.330 |
Why?
|
| Wound Healing | 1 | 2014 | 489 | 0.330 |
Why?
|
| Mitosis | 3 | 2025 | 205 | 0.320 |
Why?
|
| RNA Interference | 2 | 2011 | 549 | 0.320 |
Why?
|
| Cyclin E | 1 | 2009 | 33 | 0.320 |
Why?
|
| S Phase | 1 | 2009 | 78 | 0.310 |
Why?
|
| G1 Phase | 1 | 2009 | 67 | 0.310 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 2771 | 0.290 |
Why?
|
| Spliceosomes | 2 | 2021 | 57 | 0.290 |
Why?
|
| Genetic Vectors | 1 | 2011 | 967 | 0.260 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2669 | 0.260 |
Why?
|
| Genes, myc | 3 | 2018 | 107 | 0.240 |
Why?
|
| Cell Line, Tumor | 10 | 2025 | 3800 | 0.240 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 469 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3509 | 0.220 |
Why?
|
| Ribonucleotides | 1 | 2024 | 37 | 0.220 |
Why?
|
| Proteogenomics | 1 | 2025 | 110 | 0.220 |
Why?
|
| RNA Stability | 1 | 2024 | 87 | 0.220 |
Why?
|
| Mutation | 3 | 2015 | 6350 | 0.200 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 57 | 0.170 |
Why?
|
| Supratentorial Neoplasms | 1 | 2021 | 40 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 31 | 0.170 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2020 | 41 | 0.170 |
Why?
|
| Immunity | 1 | 2021 | 184 | 0.160 |
Why?
|
| Cell Line | 2 | 2018 | 2866 | 0.160 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 99 | 0.160 |
Why?
|
| Mice | 10 | 2025 | 19049 | 0.160 |
Why?
|
| Animals | 12 | 2025 | 36526 | 0.160 |
Why?
|
| Ependymoma | 1 | 2021 | 176 | 0.150 |
Why?
|
| Nucleosomes | 1 | 2018 | 40 | 0.150 |
Why?
|
| Acetylation | 1 | 2018 | 196 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 612 | 0.140 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2018 | 65 | 0.140 |
Why?
|
| Lysine | 1 | 2018 | 207 | 0.140 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 434 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 645 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 914 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 543 | 0.120 |
Why?
|
| Genome | 1 | 2018 | 529 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2018 | 790 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2015 | 1013 | 0.120 |
Why?
|
| RNA | 1 | 2018 | 607 | 0.110 |
Why?
|
| Histones | 1 | 2018 | 572 | 0.110 |
Why?
|
| Lipocalin-2 | 1 | 2014 | 32 | 0.110 |
Why?
|
| Gene Amplification | 3 | 2021 | 247 | 0.100 |
Why?
|
| Spindle Apparatus | 2 | 2011 | 50 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 262 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 271 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 2137 | 0.100 |
Why?
|
| beta Catenin | 1 | 2014 | 232 | 0.100 |
Why?
|
| Sirolimus | 1 | 2014 | 239 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2018 | 551 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2178 | 0.100 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 23 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1135 | 0.090 |
Why?
|
| Luminescence | 1 | 2011 | 18 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2011 | 19 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2735 | 0.090 |
Why?
|
| Gene Expression | 2 | 2014 | 1622 | 0.080 |
Why?
|
| DNA, Complementary | 1 | 2011 | 472 | 0.080 |
Why?
|
| Humans | 13 | 2025 | 134225 | 0.080 |
Why?
|
| Cell Nucleus Shape | 1 | 2009 | 2 | 0.080 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 20 | 0.080 |
Why?
|
| ran GTP-Binding Protein | 1 | 2009 | 29 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 92 | 0.080 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2009 | 37 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 62 | 0.080 |
Why?
|
| Schizosaccharomyces | 1 | 2009 | 66 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4883 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2021 | 4939 | 0.080 |
Why?
|
| Phenotype | 1 | 2018 | 4611 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 317 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2009 | 230 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3678 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2015 | 780 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 510 | 0.070 |
Why?
|
| Female | 10 | 2025 | 72054 | 0.070 |
Why?
|
| Mammary Glands, Animal | 1 | 2011 | 479 | 0.070 |
Why?
|
| Introns | 2 | 2021 | 319 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2021 | 254 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 745 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 598 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2014 | 4012 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 407 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 3056 | 0.050 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 67 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 96 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 1351 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 304 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 1087 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 39 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 181 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 323 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 11 | 0.030 |
Why?
|
| Kinetics | 1 | 2018 | 1353 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 66 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 55 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 69 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 1386 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 101 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 617 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 233 | 0.030 |
Why?
|
| Doxycycline | 1 | 2014 | 121 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1434 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1945 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 198 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 840 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 212 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 400 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 458 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 890 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 377 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 353 | 0.020 |
Why?
|
| Estradiol | 1 | 2014 | 560 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 456 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 514 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 363 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 40 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 276 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 399 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 625 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 830 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 1715 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 709 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 246 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4802 | 0.020 |
Why?
|
| ATP-Dependent Proteases | 1 | 2009 | 11 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2009 | 34 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 830 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 67 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 303 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 625 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 324 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2915 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 385 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 327 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2009 | 201 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 256 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2009 | 288 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 805 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 1922 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 949 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6595 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 13105 | 0.010 |
Why?
|
| Male | 1 | 2020 | 66215 | 0.010 |
Why?
|